Tech Center 1600 • Art Units: 1600 1611 1645 1651 1653 1655
This examiner grants 8% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16863187 | EQUOL-CONTAINING EXTRACT, METHOD FOR PRODUCTION THEREOF, METHOD FOR EXTRACTION OF EQUOL, AND EQUOL-CONTAINING FOOD | Final Rejection | OTSUKA PHARMACEUTICAL CO., LTD. |
| 17603695 | PLANT-DERIVED SCAFFOLDS FOR GENERATION OF SYNTHETIC ANIMAL TISSUE | Final Rejection | Wisconsin Alumni Research Foundation |
| 18583611 | NON-INFECTIVE NASAL SYMPTOM MANAGEMENT COMPOSITIONS AND METHODS | Final Rejection | CMPD Licensing, LLC |
| 18134210 | PRODUCT COMPRISING PROBIOTICS AND ISOMALTULOSE AND METHOD OF ITS PRODUCTION | Non-Final OA | Bluestone Pharma GmbH |
| 17999858 | COMPOSITION FOR PURIFYING RESERVOIRS FROM CYANOBACTERIA AND GREEN ALGAE | Final Rejection | LYSTERRA LLC |
| 17915306 | PHARMACEUTICAL COMPOSITION COMPRISING NEW LACTOBACILLUS PLANTARUM KC3 STRAIN AND LEONURUS JAPONICUS EXTRACT AS ACTIVE INGREDIENTS FOR PREVENTING OR TREATING RESPIRATORY DISEASE AND USE THEREOF | Non-Final OA | CKD BIO CORPORATION |
| 17774545 | PREPARATIONS FOR ENHANCED BIOCONTROL | Final Rejection | AREVO AB |
| 17719042 | INHALABLE IMATINIB FORMULATION | Final Rejection | Inaya Therapeutics, Inc. |
| 17710552 | EXTRACELLULAR MATRIX STRUCTURES | Final Rejection | Elutia Med LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy